DRUG DEVELOPMENT CONSULTANTS LTDActive
Key figures
Like most small UK companies, DRUG DEVELOPMENT CONSULTANTS LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2025/26Balance sheet structure
Filed accounts2020/21–2025/26
| 2021/22 | 2022/23 | 2023/24 | 2024/25 | 2025/26 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | — | 166,432 | 193,759 | 197,669 | — |
| Total assets | 135,597 | 175,982 | 199,023 | 203,963 | 204,045 |
| Total liabilities | — | 15,094 | 12,846 | 8,119 | 4,891 |
| Net assets / total equity | 123,204 | 161,598 | 186,709 | 196,060 | 199,154 |
| Average number of employees | 1 | 0 | 0 | 0 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: DRUG DEVELOPMENT CONSULTANTS LTD
Company
DRUG DEVELOPMENT CONSULTANTS LTD is a private limited company registered with Companies House under company number 07530075. It was incorporated on 15 Feb 2011. Its status is active. The registered office is in Shipston-on-stour (CV36). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).
Accounts
The latest accounts in the database are for 2025/26 (period ending 28 Feb 2026); the company files micro-entity accounts. Net assets were £199,154, up 1.6% on the previous year. Total assets were £204,045 and total liabilities £4,891. The company had an average of 0 employees. Figures are available for 6 financial years (2020/21–2025/26).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 30 Nov 2027. The next confirmation statement is due by 1 Mar 2027.